Lee Chan Henry 4
4 · BeOne Medicines Ltd. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Lee Chan Henry
SVP, General Counsel
Transactions
- Exercise/Conversion
American Depositary Shares
2025-12-10$194.47/sh+101$19,641→ 101 total - Exercise/Conversion
American Depositary Shares
2025-12-10$213.32/sh+133$28,372→ 234 total - Exercise/Conversion
American Depositary Shares
2025-12-10$159.03/sh+98$15,585→ 332 total - Sale
American Depositary Shares
2025-12-10$318.28/sh−332$105,669→ 0 total - Exercise/Conversion
American Depositary Shares
2025-12-11$194.47/sh+101$19,641→ 101 total - Exercise/Conversion
American Depositary Shares
2025-12-11$213.32/sh+133$28,372→ 234 total - Exercise/Conversion
American Depositary Shares
2025-12-11$159.03/sh+98$15,585→ 332 total - Sale
American Depositary Shares
2025-12-11$325.00/sh−332$107,900→ 0 total - Exercise/Conversion
Share Option (Right to Buy)
2025-12-10−1,313→ 34,385 totalExercise: $14.96Exp: 2032-08-04→ Ordinary Shares (1,313 underlying) - Exercise/Conversion
Share Option (Right to Buy)
2025-12-10−1,729→ 102,206 totalExercise: $16.41Exp: 2033-06-14→ Ordinary Shares (1,729 underlying) - Exercise/Conversion
Share Option (Right to Buy)
2025-12-10−1,274→ 121,940 totalExercise: $12.23Exp: 2034-06-04→ Ordinary Shares (1,274 underlying) - Exercise/Conversion
Share Option (Right to Buy)
2025-12-11−1,313→ 33,072 totalExercise: $14.96Exp: 2032-08-04→ Ordinary Shares (1,313 underlying) - Exercise/Conversion
Share Option (Right to Buy)
2025-12-11−1,729→ 100,477 totalExercise: $16.41Exp: 2033-06-14→ Ordinary Shares (1,729 underlying) - Exercise/Conversion
Share Option (Right to Buy)
2025-12-11−1,274→ 120,666 totalExercise: $12.23Exp: 2034-06-04→ Ordinary Shares (1,274 underlying)
Holdings
- 223,106
Ordinary Shares
Footnotes (6)
- [F1]Each American Depositary Share represents 13 Ordinary Shares.
- [F2]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.
- [F3]The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.
- [F4]These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F5]These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F6]These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.